| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050192234 Crystal forms of azithromycin |
| 09/01/2005 | US20050192232 E.g.,N[(R)-3-dodecanoyloxytetradecanoylamino]-C-aspartic acid, alpha-N-{(4R)-5-hydroxy-4-[(R)-3-hydroxytetradecanoyl- amino]pentyl}amide; grafting antigens to modulate immune response and on a pharmaceutical carrier or antibiotic to enhance therapeutic effect or targetting aqueous conjugate injections |
| 09/01/2005 | US20050191289 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption |
| 08/31/2005 | EP1567189A1 Malaria vaccine |
| 08/31/2005 | CN1662251A Adjuvant enhanced immunotherapy |
| 08/31/2005 | CN1660871A New antibiotics salt of macrolides of mandelic acid and preparation and producing method |
| 08/31/2005 | CN1660812A New medical salt and preparation in group of carbostyril mandelate and preparing method |
| 08/31/2005 | CN1660396A Gel preparation for expelling worms and promoting digestion, and preparation method |
| 08/31/2005 | CN1660066A Protective cream for preventing infection from schistosomiasis |
| 08/31/2005 | CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 08/30/2005 | US6936592 antibiotics and antiprotozoa agents |
| 08/30/2005 | US6936250 Polysaccharide encapsualted antigen |
| 08/30/2005 | CA2136331C New pharmaceutical uses of krill enzymes |
| 08/25/2005 | WO2005077934A1 Anthranilamides, process for the production thereof, and pest controllers containing the same |
| 08/25/2005 | US20050187228 Derivatives of purine, their preparation process and pharmaceutical compositions containing them |
| 08/25/2005 | US20050187215 synergistic mixture of certain previously disclosed cyclic ketoenols and agonists or antagonists of nicotinic acetylcholine receptors |
| 08/25/2005 | US20050186227 For protection of fetuses from abortion; freeze drying |
| 08/25/2005 | US20050186191 Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis |
| 08/25/2005 | CA2555503A1 Humanized anti-cd3 bispecific binding molecules having reduced immunogenicity, uses and compositions relating thereto |
| 08/24/2005 | EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 08/24/2005 | EP1565487A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 08/24/2005 | EP1356733B1 Pesticidal and antiparasitic compositions |
| 08/24/2005 | EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 08/24/2005 | CN1659163A Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 08/24/2005 | CN1659148A Aryloximes |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659139A Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament |
| 08/24/2005 | CN1658893A G-type peptides to ameliorate atherosclerosis |
| 08/24/2005 | CN1658869A N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 08/24/2005 | CN1658865A Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
| 08/24/2005 | CN1658765A Food supplement for animals |
| 08/24/2005 | CN1658757A Antihelminthic anthraquinones and method of use thereof |
| 08/24/2005 | CN1215768C Active ingredient compositions having insecticidal and acaricidal properties |
| 08/23/2005 | US6933279 Peptides comprising a class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini |
| 08/23/2005 | US6933130 Recombinants process for preparing a complete malaria antigen, gp190/MSP1 |
| 08/23/2005 | US6932960 Complexes with radionuclides; for use as contrast agent in magnetic resonance imaging (MRI); as parasiticide, viricide, or as chelation therapy of iron overload such as thalassemia; optimal combination of lipophilicity and hydrophilicity |
| 08/23/2005 | CA2111571C Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | US20050182130 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 08/18/2005 | US20050182127 Broad activity spectrum against both endo- and ectoparasites in and on warm-blooded animals and plants; antihelmintics; nematocides |
| 08/18/2005 | US20050182017 Immunostimulatory nucleic acid molecules |
| 08/18/2005 | US20050180996 Vaccine composition specific to glyceroaldehyde-3-phosphate dehydrogenase for use as tool in prevention and treatment of coccidiosis; veterinary medicine |
| 08/18/2005 | US20050180985 Live attenuated salmonella strains for producing monovalent or multivalent vaccines |
| 08/18/2005 | US20050180978 Isolated monoclonal antibody mAb PAB-1, deposited at ATCC on 24 Jan. 2002 and accorded accession PTA-4005, which binds to a surface antigen on nematode L3; use in preventing or treating animal nematode infections |
| 08/18/2005 | DE10134196B4 Pharmazeutische Zusammensetzung zur Hemmung der unkontrollierten Vermehrung und/oder Induzierung der Apoptose von Zellen A pharmaceutical composition for inhibiting uncontrolled proliferation and / or inducing apoptosis of cells |
| 08/18/2005 | CA2553039A1 Antiparasitic composition |
| 08/17/2005 | EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 08/17/2005 | EP1140103B1 Ponazuril for treating neurologic and abortigenic diseases caused by coccidia. |
| 08/17/2005 | EP0833917B1 Malarial pre-erythrocytic stage polypeptide molecules |
| 08/17/2005 | CN1656122A Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 08/17/2005 | CN1656101A Esters in position 20 of camptothecins |
| 08/17/2005 | CN1656100A Camptothecins with a modified lactone ring |
| 08/17/2005 | CN1656061A Organic compounds |
| 08/17/2005 | CN1655673A Methods and compositions for treating ectoparasite infestation |
| 08/16/2005 | US6930085 G-type peptides to ameliorate atherosclerosis |
| 08/16/2005 | US6929955 Interactive system for presenting and eliminating substances |
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/11/2005 | US20050176942 Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov. |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
| 08/11/2005 | US20050176819 parasiticides, in particularly against Plasmodium and babesia; antimalarial agents |
| 08/11/2005 | US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis |
| 08/11/2005 | US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders |
| 08/11/2005 | US20050176815 Malaria therapy |
| 08/11/2005 | US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors |
| 08/11/2005 | US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176685 Administering bisphosphonate compounds such as ibandronate, minodronate, pamidronate, risedronate, zoledronate, and alendronate; osteoporosis |
| 08/11/2005 | US20050176094 Polypeptide having immunomodulatory activity, antiviral activity, and antitumor activity; polynucleotides, expression vectors , probes and antibodies; predicting responsiveness to treatment with interferon- alpha and other interferons which act at the Type 1 interferon receptor |
| 08/11/2005 | US20050175621 Adjuvant composition comprising FHA protein or a fragment of FHA protein in its free form |
| 08/11/2005 | CA2552392A1 Apicomplex vaccine strains of a family of sarcocystidae |
| 08/10/2005 | EP1561820A1 Novel substance fki-1033 and process for producing the same |
| 08/10/2005 | EP1561463A2 Benzamidoxime prodrugs as antipneumocystic agents |
| 08/10/2005 | EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 08/10/2005 | EP1560574A2 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin |
| 08/10/2005 | EP1560488A2 Antibacterial agents |
| 08/10/2005 | EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 08/10/2005 | EP0914150B1 Recombinant neospora antigens and their uses |
| 08/10/2005 | CN1653089A Organic medicine and betacyclodextrin derivative and preparation process thereof |
| 08/10/2005 | CN1653059A Macrocyclic compounds useful as pharmaceuticals |
| 08/10/2005 | CN1653049A Pesticidal pyridinecarboxamide derivatives |
| 08/10/2005 | CN1653048A Pyridine carboxamide derivatives and their use as pesticides |
| 08/10/2005 | CN1653044A Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 08/10/2005 | CN1653039A Amidoacetonitrile compounds and their use as pesticides |
| 08/10/2005 | CN1652820A Methods of treatment using CTLA-4 antibodies |
| 08/10/2005 | CN1652816A Methods for the in vitro culture of sporozoea sp. and uses thereof |
| 08/10/2005 | CN1652779A Treatment of chemokine mediated diseases |
| 08/10/2005 | CN1652754A Tasted masked veterinary solid compositions |
| 08/10/2005 | CN1651002A Chinese medicinal composition, its preparation method and application |
| 08/10/2005 | CN1650854A Preparation technology of micro emulsion containing artemisic methyl ether (or artemisic ethyl ether or artemisic succinate) |
| 08/10/2005 | CN1213756C Veterinary compositions for treatment of parasitic diseases |
| 08/10/2005 | CN1213659C Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and composition containing the same |
| 08/09/2005 | US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents |
| 08/09/2005 | US6926898 Albumin fusion proteins |
| 08/04/2005 | WO2005070421A1 Fluconazole-tinidazole combination for the treatment of vaginal infections, composition thereof and preparation and use of same |
| 08/04/2005 | US20050171183 Indole-type inhibitors of p38 kinase |
| 08/04/2005 | US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors |